Mandate
To provide recommendations to the Board and the Registrar on matters relating to pharmacy legislation and policy review.
Membership
Justin Thind (Chair, effective November 15, 2019)
Mona Kwong (Chair, until November 15, 2019)
Andrea Silver (Vice-Chair, until November 15, 2019)
Anu Sharma (staff resource - acting for Christine Paramonczyk)
Bal Dhillion
Claire Ishoy (effective November 15, 2019)
Number of Meetings: 4
Accomplishments of the Year
Over the past year, the Legislation Review Committee recommended the following changes to policy, bylaws, fees, and Standards of Practice:
| Legislation |
Amendments |
|---|
| Health Professions Act (HPA) Bylaws |
April 2019
- Approval to publicly post amendments to committee member terms of office for a 90-day period.
- Approval to publicly post amendments authorizing the Registrar to act under s. 32(3) of the HPA for a 90-day period.
- Approval to file HPA fee amendments with the Minister of Health.
June 2019
- Approval to file housekeeping amendments to “Schedule C” of the HPA bylaws related to updating of recognized education programs with the Minister of Health.
September 2019
- Approval to file amendments to committee member terms of office with the Minister of Health.
- Approval to file amendments authorizing the Registrar to act under s. 32(3) of the HPA with the Minister of Health..
February 2020
- Approval for amendments to the Controlled Prescription Program Form under the HPA
|
|
Pharmacy Operations and Drug Scheduling Act (PODSA) Bylaws
|
June 2019
- Approval to publicly post amendments relating to Phase Two of the PODSA Modernization initiative for a 90-day period.
- Approval to file amendments to remove “Schedule C” and “E” related to telepharmacy licence requirements which were moved to bylaw.
September 2019
- Approval to file PODSA fee amendments with the Minister of Health.
November 2019
- Approval to file amendments relating to Phase Two of the PODSA Modernization initiative with the Minister of Health.
|
| Professional Practice Policies (PPP) |
June 2019
- Repealing of multiple professional practice policies under the PODSA Modernization Phase II Project
September 2019
- Approval of amendments to PPP-3 Pharmacy References to remove the requirement for all community pharmacies and telepharmacies to have a copy of the BC Pharmacy Practice Manual.
- Approval of amendment to PPP-76 Criminal Record History Vendor to reflect the name change of the approved criminal record history vendor from Sterling Talent Solutions to Sterling Backcheck.
November 2019
- Approval of amendments to multiple professional practice policies under the PODSA Modernization Phase II Project.
February 2020
- Amendments to PPP-68 Cold Chain Management of Biologicals
- Amendments to PPP-71 Delivery of Methadone for Maintenance and consequential amendments to PPP-66 and its Policy Guides
|
| Drug Schedules Regulation (DSR) |
April 2019
- Approval of amendments with respect to the scheduling of esomeprazole (to move esomeprazole when sold for treatment of frequent heartburn from Schedule II to Schedule III and establish esomeprazole for veterinary use as Schedule I) for filing with the Minister of Health.
September 2019
- Approval of amendments to move certain Schedule I codeine containing liquid preparations to Schedule IA, for filing with the Minister of Health.
|
Goals for Next Fiscal Year
- Initiate scoping a comprehensive review and reform of legislative requirements under the Health Professions Act.
- Development of bylaws adopting the National Association of Pharmacy Regulatory Authorities Model Standards for Sterile Compounding.
- Assist with the development of an implementation recommendation regarding NAPRA’s Model Standards for Non-Sterile Compounding.
